The Clorox CompanyCLXNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +27.13% | -15.28% | -8.05% | +4.47% | -18.90% |
| Gross Profit Growth | +51.31% | -14.44% | -2.89% | +4.78% | -26.49% |
| EBITDA Growth | +123.68% | +41.89% | +700.00% | +37.43% | -25.88% |
| Operating Income Growth | +360.94% | -27.64% | +9.17% | +31.87% | -58.31% |
| Net Income Growth | +350.00% | +107.53% | +0.00% | +53.70% | -19.19% |
| EPS Growth | +344.44% | +108.00% | +0.00% | +55.17% | -18.75% |
| EPS Diluted Growth | +338.89% | +105.33% | +0.00% | +54.91% | -17.72% |
| Weighted Average Shares Growth | -0.14% | -0.33% | -0.71% | -0.91% | -0.94% |
| Weighted Average Shares Diluted Growth | +0.02% | +0.03% | -0.15% | -1.05% | -1.33% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +1005.00% | +17.65% | +57.14% | -13.53% | -57.92% |
| Free Cash Flow Growth | +0.00% | +25.74% | +83.46% | -15.44% | -68.68% |
| Receivables Growth | +2.41% | -11.19% | -11.29% | +18.13% | +18.15% |
| Inventory Growth | -16.34% | -9.62% | -5.79% | -17.90% | -2.86% |
| Asset Growth | -8.25% | -5.60% | -5.05% | -3.30% | +0.56% |
| Book Value per Share Growth | +0.00% | +0.00% | -70.12% | -1.24% | +0.00% |
| Debt Growth | -9.96% | -1.18% | -2.52% | -0.79% | +6.73% |
| R&D Expense Growth | +6.90% | -3.13% | -15.63% | -3.03% | -9.68% |
| SG&A Expenses Growth | +9.30% | -6.73% | -7.24% | -11.22% | -8.09% |